Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps
P Wei, GW Kaatz, RJ Kerns
Index: Wei, Peng; Kaatz, Glenn W.; Kerns, Robert J. Bioorganic and Medicinal Chemistry Letters, 2004 , vol. 14, # 12 p. 3093 - 3097
Full Text: HTML
Citation Number: 19
Abstract
In this study the chemical modification of paroxetine was employed to determine which structural differences between the paroxetine-like and femoxetine-like selective serotonin reuptake inhibitors is responsible for the differential potency of these agents in the inhibition of Staphylococcus aureus multidrug efflux pump systems.
Related Articles:
Synthesis of the major metabolites of Paroxetine
[Segura, Mireia; Roura, Lidia; De La Torre, Rafael; Joglar, Jesus Bioorganic Chemistry, 2003 , vol. 31, # 3 p. 248 - 258]
Synthesis of the major metabolites of Paroxetine
[Bioorganic Chemistry, , vol. 31, # 3 p. 248 - 258]
Improved Process for Paroxetine Hydrochloride Substantially Free from Potential Impurities
[Synthetic Communications, , vol. 42, # 22 p. 3344 - 3360]